Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples